Collectively, our findings for the first time highlight a broad spectrum of ACLY functions in liver as well as in the pathogenesis of MASH and its diagnostic and therapeutic potential value. This evidence concerns the gene ACLY and metabolic dysfunction-associated steatohepatitis.